Clinical trial
Evaluation of the Effect of Ketanserine on Sublingual Microcirculation by SDF Imaging in Septic Patients on the Intensive Care
NCT01329887 is registered in ClinicalTrials.gov with Frisius Medisch Centrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Ketanserine on Sublingual Microcirculation by SDF Imaging in Septic Patients on the Intensive Care
- Lead sponsor
- Frisius Medisch Centrum
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- May 31, 2014
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock, severe sepsis